Digg It - Business

If you are in management it behooves you to learn about finite capacity scheduling

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

models and how you can increase your output in your production cycles. Efficiency

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

is indeed the name of the game when it comes to output and low costs. I therefore

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

recommend the book; here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

etail/-/0471352640/ref=cm_aya_asin.title/102-8128418-4913762?%5Fencoding=UTF8&v=gl

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ance" target="_blank" rel="nofollow">Finite Capacity Scheduling : Manageme

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

nt, Selection, and Implementation (Oliver Wight Manufacturing) by Ger

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

hard Plenert.

I believe that this book should be required reading for all MBA Stu

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

dents and taught as part of the course curriculum at the top business schools. Do

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

I believe you should also read the book on Finite Capacity Scheduling, absolutely

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

if you are serious about the efficiencies in your company and indeed the knowledge

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

will serve you very well. I also have considered the fact that they should use

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

it to teach MBA Students at Yale, Harvard, Stanford and Wharton too. These theorie

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

s and management practices of finite capacity scheduling I believe can also be app

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

lied to other industries; such as car washing production lines, agriculture models

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

, services businesses and a host of other things as well; everything from HMO pati

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ent operations to search and rescue grid searches for survivors.

If you consider

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

how we can keep up the smaller and smaller margins in the manufacturing sector it

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

is amazing things still work. Yet if you follow the finite capacity scheduling mod

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

els you will see it is possible and it makes sense too. Consider all this in 2006.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/22572/diggit-Finite-Capacity-Scheduling-Management-Issues.html">Finite Capacity Scheduling; Management Issues</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/22572/diggit-Finite-Capacity-Scheduling-Management-Issues.html]Finite Capacity Scheduling; Management Issues[/url]

I run a small meeting, event and conference planning company based in the New York City area. As an entrepeneur and small business owner with a limited advertising and marketing budget, developing business partnerships has been really helped me to get the word out...

While every business has, or should have a business card, often it is neglected as a part of an overall strategy. If you take the time to devise even a simple marketing, public relations, or sales strategy, your business card should be an integral part of your plan.

How often do you answer your emails? Do you respond to them right away or wait until the end of the day? This is a small dilemma that comes up quite often for self-employed individuals.

Tags

Links

Digg It - Finite Capacity Scheduling; Management Issues

Related Articles: